Details Of Published TSH Receptor Mutation

Back To All Mutations

Cys 390 Phe

c.1169G>T

Inactivating TSH Receptor Mutation

Type

loss

Manifestation

sporadic

Exon

Molecular Characteristics:

Yamaguchi et al. 2 cases co-occuring with R450H

Clinical Features:

Treatment:

Functional Characteristics:

cAMP
(basal)

cAMP
(TSH)

IP
(basal)

IP
(TSH)

TSH-Binding

Cell Surface Expression

Prevalence

LRA

Ref

227

Legend:

cAMP (basal): basal in vitro cAMP production of mutant over wild-type TSHR

cAMP (TSH): maximal in vitro cAMP production of mutant over wild-type TSHR

IP (basal): basal in vitro IP production of mutant over wild-type TSHR

IP (TSH): maximal in vitro IP production of mutant over wild-type TSHR

TSH-binding: maximal TSH-binding compared to the wild-type TSHR

Cell surface expression: cell surface expression of mutant compared to WT-TSHR

LRA: linear regression analysis (LRA) of constitutive activity as a function of TSHR expression determined by 125I-bTSH binding or FACS analysis compared to the wild-type TSHR

Prevalence: Prevalence of (somatic and germline) activating mutations*

Ref: Reference for functional characterization

Child: Found in children.

Reference 1:

Yamaguchi et al.

JCEM

Targeted next-generation sequencing for congenital hypothyroidism with positive neonatal TSH screening

2020

Abstract In Medline Available